Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FFL4D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,001
Award facts
- Contract value 100% obligated
- $26,001.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $26,001.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 26, 2026, for the supply of RINVOQ ER 15 mg tablets (30-count units). This competitively awarded, non-set-aside contract is a child order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999.99 million through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 27, 2026.
This delivery order represents a routine pharmaceutical procurement supporting military healthcare programs through DLA's existing pharmaceutical supply chain infrastructure. AmerisourceBergen, operating as a subsidiary of Cencora, Inc., serves as a critical vendor for federal medical procurement and supplies a comprehensive range of pharmaceutical products, medical devices, and healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The firm fixed-price structure and rapid fulfillment timeline reflect the operational efficiency of this established contract vehicle for delivering essential medications to military treatment facilities and veteran healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FFL4D?
SPE2DR26FFL4D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FFL4D worth?
The government has obligated $26,001 on SPE2DR26FFL4D.
Is contract SPE2DR26FFL4D an order under another contract?
Yes. SPE2DR26FFL4D is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFL4D competed?
The extent of competition for SPE2DR26FFL4D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award